research use only

Flunarizine 2HCl Calcium Channel inhibitor

Cat.No.S2030

Flunarizine 2HCl (KW-3149, R14950) is a dihydrochloride salt form which is a calcium channel blocker with a Ki of 68 nM.
Jump to

Quality Control

Batch: Purity: 99.93%
99.93

Solubility

In vitro
Batch:

DMSO : 5 mg/mL (10.47 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Ethanol : 3 mg/mL

Water : Insoluble

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Chemical Information, Storage & Stability

Molecular Weight 477.42 Formula

C26H26F2N2.2HCl

Storage (From the date of receipt)
CAS No. 30484-77-6 Download SDF Storage of Stock Solutions

Synonyms KW-3149, R14950 SMILES C1CN(CCN1CC=CC2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F.Cl.Cl

Read more about storage stability stock solution CAS number SMILES

Mechanism of Action

Targets/IC50/Ki
Calcium channel
68 nM(Ki)

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2026-08-07)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT07751497 NOT_YET_RECRUITING
Vestibular Migraine
Second Affiliated Hospital, Zhejiang University, School of Medicine
2026-12-01 PHASE2
NCT07655700 NOT_YET_RECRUITING
Migraine Prophylaxis
Chittagong Medical College
2026-07-01 PHASE4
NCT07068815 NOT_YET_RECRUITING
Migraine Without Aura
Guangzhou University of Chinese Medicine
2025-09-01 PHASE1
NCT06499116 NOT_YET_RECRUITING
Migraine
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
2024-10 PHASE4
NCT07445464 NOT_YET_RECRUITING
Pharmacokinetic Analysis
Aspartes Pharmaceuticals, Inc.
2026-04-09 PHASE1
NCT07354126 RECRUITING
Migraine
Muhammad Aamir Latif
2025-09-01

Read more about Clinical Trials

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Signaling Pathway Map